51
|
Nandan A, Sharma V, Singh H, Chandra A, Tripathi R, Dhirendra S, Mehrotra R. Alternate Splicing in Head and Neck Cancer: An Update. J Glob Oncol 2018. [DOI: 10.1200/jgo.18.19600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Background: Alternate splicing (AS) is a regulatory process during gene expression that allows a single gene to code multiple proteins. Sequencing of RNA (RNA-Seq) is a high throughput technology, which has been used in various studies to identify AS mechanisms in head and neck cancer (HNC). Until date, there is no available review that could update us with the major outcomes from these studies. Aim: To perform a comprehensive literature search for AS studies on HNC via RNA-Seq. Methods: A systematic literature search was performed following PRISMA guidelines to give a complete picture of AS in HNC identified through RNA-Seq. In addition, comprehensive search was also performed to identify the bioinformatics softwares that analyses RNA-Seq data for finding AS in cancer. Results: Six studies were found that used RNA-Seq data for identifying AS events in HNC. Five softwares were used by these studies to identify AS events, of which Suppa and AltAnalyze can also categorize all four AS events to subtypes, i.e., cassette exon skipping (ES), intron retention (IR), mutually exclusive exon (MXE), and alternative 5′ and 3′ splice site (ASS). Additionally, SplAdder, ASprofile, JuncBASE, and MATS softwares have been used to identify and categorize AS events in cancers other than HNC. Conclusion: Alternate splicing in HNC is a complex regulatory process of gene expression. It can be studied through RNA-Seq using various bioinformatics softwares. SplAdder, ASprofile, JuncBASE, and MATS have been used to identify and characterize other cancers, but not implemented in HNC, and hence could be used for studying AS in HNC.
Collapse
|
52
|
Mehrotra R. Three-dimensional echocardiographic systolic dyssynchrony index- what is the correct cut-off? Indian Heart J 2018; 70:765. [PMID: 30392522 PMCID: PMC6204474 DOI: 10.1016/j.ihj.2018.08.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Revised: 08/20/2018] [Accepted: 08/21/2018] [Indexed: 11/11/2022] Open
|
53
|
R. Smith S, Holmes R, Pockney P, Holz P, Carroll R, Mehrotra R. Response to Re: Randomized clinical trial to assess the ideal mode of delivery for local anaesthetic abdominal wall blocks. ANZ J Surg 2018. [DOI: 10.1111/ans.14766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
54
|
Mehrotra R, Bhat S, Jain A. Recent trials exploring newer approaches for incremental reduction in cardiovascular risk. JOURNAL OF CLINICAL AND PREVENTIVE CARDIOLOGY 2018. [DOI: 10.4103/jcpc.jcpc_11_18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
55
|
Mehrotra R, Bhat S, Sharma A, Kumar R. Giant left atrium in mitral stenosis. JOURNAL OF THE INDIAN ACADEMY OF ECHOCARDIOGRAPHY & CARDIOVASCULAR IMAGING 2018. [DOI: 10.4103/jiae.jiae_45_17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
56
|
Holmes R, Smith SR, Carroll R, Holz P, Mehrotra R, Pockney P. Randomized clinical trial to assess the ideal mode of delivery for local anaesthetic abdominal wall blocks. ANZ J Surg 2017; 88:786-791. [DOI: 10.1111/ans.14317] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2017] [Revised: 09/11/2017] [Accepted: 09/13/2017] [Indexed: 01/13/2023]
|
57
|
Mehrotra R. Landmark trials in pulmonary hypertension and pulmonary embolism. JOURNAL OF CLINICAL AND PREVENTIVE CARDIOLOGY 2017. [DOI: 10.4103/2250-3528.196658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
58
|
Iyengar SS, Puri R, Narasingan SN, Wangnoo SK, Mohan V, Mohan JC, Misra A, Sriram U, Dalal JJ, Gupta R, Prabhakar D, Kerkar P, Zargar AH, Kasliwal RR, Mehrotra R, Kumar S, Chakraborty R, Chadha M, Daga MK, Seshadri K, Paul J, Kavalipati N, Kapoor D, Narain VS, Rastogi A, Muruganathan A, Gupta A, Murthy S, Bordoloi N, Sahoo PK, Agarwal RK, Chag M, Rajput R, Melinkeri RP. Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1. THE JOURNAL OF THE ASSOCIATION OF PHYSICIANS OF INDIA 2016; 64:7-52. [PMID: 28762263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
|
59
|
Mehrotra R. Yoga and the heart. JOURNAL OF CLINICAL AND PREVENTIVE CARDIOLOGY 2016. [DOI: 10.4103/2250-3528.192697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
60
|
Gupta M, Husain N, Mehrotra R. PO-103: Comparison of VEGF Expression in non malignant, premalignant lesion and squamous cell carcinoma of oral cavity. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)34863-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
61
|
Kumar S, Mehrotra R, Puri S. PR22 Lymphatic cancer spread assessment by podoplanin (D2-40) in breast cancer. Breast 2014. [DOI: 10.1016/s0960-9776(14)70032-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
62
|
Mehrotra R, Sarat Chandra K. Quo vadis cardiology? Indian Heart J 2014; 66:151-2. [DOI: 10.1016/j.ihj.2014.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
63
|
Mehrotra R, Bansal M, Kasliwal RR. Manual of 3D Echocardiography. Indian Heart J 2014. [PMCID: PMC3946462 DOI: 10.1016/j.ihj.2013.12.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
64
|
Mehrotra R. Q&A: Elephant man. Interview by Laura Spinney. Nature 2013; 497:316. [PMID: 23676742 DOI: 10.1038/497316a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
65
|
Woldemeskel FM, Sharma A, Sivakumar B, Mehrotra R. An error estimation method for precipitation and temperature projections for future climates. ACTA ACUST UNITED AC 2012. [DOI: 10.1029/2012jd018062] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
66
|
Kasliwal RR, Bansal M, Agrawal V, Dandona P, Mehrotra R, Garg R. Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India. Metab Syndr Relat Disord 2012; 2:169-71. [PMID: 18370682 DOI: 10.1089/met.2004.2.169] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
|
67
|
Bansal M, Mehrotra R, Kasliwal RR. Loss of left ventricular torsion as the predominant mechanism of left ventricular systolic dysfunction in a patient with tubercular cardiomyopathy. Echocardiography 2012; 29:E221-5. [PMID: 22748130 DOI: 10.1111/j.1540-8175.2012.01768.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Pericarditis is the commonest form of cardiac involvement in tuberculosis whereas myocardial involvement is exceedingly rare. We hereby report a patient who presented with cardiac tuberculosis manifesting as predominantly right-sided cardiomyopathy. In addition to being a very rare clinical presentation, this case provided an interesting insight into the left ventricular (LV) myocardial mechanics. The patient had nearly preserved contractile function of the LV myocardium (except for segmental abnormalities in circumferential strain) but had marked impairment of torsion resulting in LV systolic dysfunction. Such disproportionate loss of LV torsion leading to LV systolic dysfunction has not been previously described on echocardiography. These myocardial mechanical abnormalities almost completely recovered with adequate antitubercular treatment. Thus, this case proved to be a unique demonstration of the significant, independent role played by torsion in maintenance of normal LV systolic function.
Collapse
|
68
|
Shankar B, Mehrotra R, Bansal M, Singh G, Kasliwal RR. Quadricuspid aortic valve. THE JOURNAL OF THE ASSOCIATION OF PHYSICIANS OF INDIA 2012; 60:54-55. [PMID: 23409427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Quadricuspid aortic valve is a rare congenital heart defect usually detected by echocardiography or at the time of aortic valve surgery. Preoperative recognition of this abnormality has clinical significance because it is frequently associated with other congenital cardiac abnormalities and anomalies of coronary origin. We report a case of quadricuspid aortic valve, which was detected preoperatively by transthoracic echocardiography and was associated with severe aortic regurgitation.
Collapse
|
69
|
Grewal H, Mehrotra R, Kasliwal RR. Scleroderma cardiac disease. THE JOURNAL OF THE ASSOCIATION OF PHYSICIANS OF INDIA 2011; 59:676-677. [PMID: 22479758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
|
70
|
Chiu YW, Mehrotra R. Can we reduce the cardiovascular risk in peritoneal dialysis patients? Indian J Nephrol 2011; 20:59-67. [PMID: 20835317 PMCID: PMC2931134 DOI: 10.4103/0971-4065.65296] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
Patients with end-stage renal disease (ESRD), including those treated with peritoneal dialysis (PD), have a high risk for death, particularly from cardiovascular (CV) causes. Traditional risk factors for CV disease – like hypertension, diabetes, and dyslipidemia - are highly prevalent, often severe, and more difficult to treat in dialysis patients. Development of strategies for CV risk reduction in dialysis patients is complicated by epidemiologic studies that demonstrate paradoxical associations of some of the traditional risk factors with mortality. The difficulty is enhanced by either a paucity or negative findings of studies that have tested risk modification by targeting traditional CV risk factors. It is also clear that neither the prevalence nor the severity of traditional risk factors explains the substantial increase in risk for death associated with ESRD; this has led to identification of several nontraditional risk factors. Among these, systemic inflammation, disordered mineral metabolism, and long-term CV risk from infectious complications appear the most promising. However, the evidence in favor of the importance of these risk factors is largely limited to observational studies. In this review, we present a critical analysis of the literature to assist the clinician to reduce the CV risk of ESRD patients treated with PD.
Collapse
|
71
|
Chaudhary A, Pandya S, Mehrotra R, Bharti A, Singh M, Singh M. P73. Comparison between the hybrid capture II test and PCR for the detection of human papillomavirus DNA in OSMF and OSCC. Oral Oncol 2011. [DOI: 10.1016/j.oraloncology.2011.06.316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
72
|
Chaudhary A, Pandya S, Singh M, Bharti A, Singh M, Mehrotra R. P140. Role of matrix metallo-proteinase-3 promoter (-1171 5A/6A) polymorphism in oral submucous fibrosis and head and neck lesions. Oral Oncol 2011. [DOI: 10.1016/j.oraloncology.2011.06.383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
73
|
Otero S, Mehrotra R. Structural Neuroimaging in First-Episode Psychosis: a review of neuroimaging practice in an early intervention service. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)72652-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
IntroductionThe UK NICE technology guidance “Structural Neuroimaging in First-Episode Psychosis” concludes that CT/MRI is not routinely recommended as an initial investigation for first-episode psychosis.ObjectivesTo evaluate the use of CT/MRI in a group of Early Intervention Service (EIS) patients with a first-episode psychosis aged 18–35 years at presentation.AimsTo develop practice guidelines for use of neuroimaging in first-episode psychosis.MethodsAll 107 patients registered with the EIS in Hounslow, London, UK, were eligible for inclusion in this review. Data was collected from the medical records and the Picture Archiving and Communications System. Data was analysed using a microsoft excel data analysis tool. Additionally, comparisons were made between the group of patients with normal scans and that with abnormal scans. Statistical significance was determined using the chi-squared method with a significance of P < 0.05.Results17 patients had documented neuroimaging results. 4 scans were abnormal. There was no significant difference between the group with normal and abnormal scans in terms of gender, abnormalities of physical/neurological health, blood tests and whether the patient had any additional medical conditions. Abnormal scan results did not influence treatment or outcome for any patient.ConclusionsThe abnormal scans were not correlated to clinical indices of history, examination and laboratory tests. Abnormal scans appear to have a low yield in terms of clinical effectiveness. The findings support selective use of neuroimaging in this cohort of patients. The indications for it usage would appear to rely on clinical judgement as well clinical findings.
Collapse
|
74
|
Mehrotra R, Mehrotra V, Jandoo T. Tobacco control legislation in India: past and present. Indian J Cancer 2010; 47 Suppl 1:75-80. [PMID: 20622419 DOI: 10.4103/0019-509x.63870] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Beginning with the Cigarettes Act, 1975, a number of legislative strategies and programs to curb tobacco use have been implemented in India, with limited success. Currently, the Cigarettes and Other Tobacco Products Act, 2003, is designed to curb the use of tobacco in order to protect and promote public health. This review presents a critical appraisal of the current situation in its historical context.
Collapse
|
75
|
Mehrotra R, Norris K. Hypovitaminosis D, neighborhood poverty, and progression of chronic kidney disease in disadvantaged populations. Clin Nephrol 2010; 74 Suppl 1:S95-S98. [PMID: 20979972 PMCID: PMC3191381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
In the United States, there are significant racial disparities in the incidence and prevalence of end-stage renal disease. The disparities are greatest for the Blacks and the magnitude of disparity is significantly greater than is evident from the incidence and prevalence data of end-stage renal disease - early stage chronic kidney disease is less common in Blacks and during that stage, mortality rate is significantly higher for that racial group. Recent studies have identified a genetic predisposition for non-diabetic renal disease among Blacks. However, genetic factors explain only part of the higher risk and the racial disparities are a result of a complex interplay of biology and sociology. Herein we focus on two factors and their role in explaining the higher risk for progression of chronic kidney disease among Blacks - one biologic (vitamin D deficiency) and one sociologic (neighborhood poverty). A greater Understanding of these factors is important in order to reduce the racial disparities in the United States.
Collapse
|